ARK Genomic Revolution ETF vs Impinj Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Impinj Inc trades at $177.62 (market cap $5.32B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Impinj Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | PI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $241.91 |
52-Week Low | $24.02 | $91.34 |
Market Cap | — | $5.32B |
Enterprise Value | — | $5.45B |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →